Beemnet W. Dada

Array ( [id] => 7270471 [patent_doc_number] => 20040058989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Pharmaceutical composition containing citalopram' [patent_app_type] => new [patent_app_number] => 10/619743 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2873 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058989.pdf [firstpage_image] =>[orig_patent_app_number] => 10619743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005495 [patent_doc_number] => 06906092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Method of inhibiting matrix metalloproteinases' [patent_app_type] => utility [patent_app_number] => 10/603677 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10363 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906092.pdf [firstpage_image] =>[orig_patent_app_number] => 10603677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368357 [patent_doc_number] => 20040006122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Methods of treating skin disorders using thio-oxindole derivatives' [patent_app_type] => new [patent_app_number] => 10/601442 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13115 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006122.pdf [firstpage_image] =>[orig_patent_app_number] => 10601442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256251 [patent_doc_number] => 20040259834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Therapeutic composition containing at least diflomotecan and capecitabine' [patent_app_type] => new [patent_app_number] => 10/465309 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1675 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259834.pdf [firstpage_image] =>[orig_patent_app_number] => 10465309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404502 [patent_doc_number] => 20040023990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Use of pyrazolo[4,3-d]pyrimidines' [patent_app_type] => new [patent_app_number] => 10/432772 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6327 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023990.pdf [firstpage_image] =>[orig_patent_app_number] => 10432772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325272 [patent_doc_number] => 20040138178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Phosphono-carboxylate compounds for treating amyloidosis' [patent_app_type] => new [patent_app_number] => 10/447310 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9458 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138178.pdf [firstpage_image] =>[orig_patent_app_number] => 10447310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 654853 [patent_doc_number] => 07109198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => 'Method for treating obesity' [patent_app_type] => utility [patent_app_number] => 10/440404 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5424 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109198.pdf [firstpage_image] =>[orig_patent_app_number] => 10440404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136507 [patent_doc_number] => 20040044083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Exo-S-mecamylamine formulation and use in treatment' [patent_app_type] => new [patent_app_number] => 10/441947 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12885 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044083.pdf [firstpage_image] =>[orig_patent_app_number] => 10441947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428056 [patent_doc_number] => 20040229951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Method of treating fatigue by enhancing the effectiveness of the human immune system' [patent_app_type] => new [patent_app_number] => 10/439207 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1428 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229951.pdf [firstpage_image] =>[orig_patent_app_number] => 10439207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711648 [patent_doc_number] => 20030171397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Potentiation of antineoplastic agents using sigma-2' [patent_app_type] => new [patent_app_number] => 10/275830 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7829 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171397.pdf [firstpage_image] =>[orig_patent_app_number] => 10275830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664585 [patent_doc_number] => 20030203911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => '5-Arylsulfonyl-imidazo[1\',2\':1,6]pyrido[2,3-b]pyrazine-6-amines and related compounds' [patent_app_type] => new [patent_app_number] => 10/424451 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5119 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203911.pdf [firstpage_image] =>[orig_patent_app_number] => 10424451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701080 [patent_doc_number] => 20030223960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4\'-trifluoromethylphenyl)-amide for treating multiple sclerosis' [patent_app_type] => new [patent_app_number] => 10/413976 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3015 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20030223960.pdf [firstpage_image] =>[orig_patent_app_number] => 10413976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1147536 [patent_doc_number] => 06774143 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Method for treating cells resistant to antineoplastic agents' [patent_app_type] => B1 [patent_app_number] => 10/240645 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10387 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774143.pdf [firstpage_image] =>[orig_patent_app_number] => 10240645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136243 [patent_doc_number] => 20040043990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Method of treatment' [patent_app_type] => new [patent_app_number] => 10/410311 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2228 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043990.pdf [firstpage_image] =>[orig_patent_app_number] => 10410311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 993722 [patent_doc_number] => 06916821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Methods of treating disorders with Group I mGluR antagonists' [patent_app_type] => utility [patent_app_number] => 10/408771 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 36 [patent_no_of_words] => 29850 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916821.pdf [firstpage_image] =>[orig_patent_app_number] => 10408771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972243 [patent_doc_number] => 06936628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Oral administration of epothilones' [patent_app_type] => utility [patent_app_number] => 10/404324 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20395 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 399 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936628.pdf [firstpage_image] =>[orig_patent_app_number] => 10404324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639997 [patent_doc_number] => 20030212078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Topical administration of pharmacological compositions for non-systemic treatment of pruritus' [patent_app_type] => new [patent_app_number] => 10/276508 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4271 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212078.pdf [firstpage_image] =>[orig_patent_app_number] => 10276508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972233 [patent_doc_number] => 06936618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Cystic fibrosis medicaments' [patent_app_type] => utility [patent_app_number] => 10/394220 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3692 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936618.pdf [firstpage_image] =>[orig_patent_app_number] => 10394220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1197353 [patent_doc_number] => 06727357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-27 [patent_title] => 'Liquid thickener for surfactant systems' [patent_app_type] => B2 [patent_app_number] => 10/391256 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4790 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727357.pdf [firstpage_image] =>[orig_patent_app_number] => 10391256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639192 [patent_doc_number] => 20030212014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Methods fo treating conditions associated with insulin resistance with aicar, (5-amino-4-imidazole carboxamide riboside) and related compounds' [patent_app_type] => new [patent_app_number] => 10/343399 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 8617 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212014.pdf [firstpage_image] =>[orig_patent_app_number] => 10343399 [rel_patent_id] =>[rel_patent_doc_number] =>)